Reduction in atrial and pulmonary vein stretch as a therapeutic target for prevention of atrial fibrillation

Atrial fibrillation (AF) is a common cardiac arrhythmia that is asso-ciated with increased mortality. Heart failure, hypertension, valvular disease, and obstructive sleep apnea are risk factors for incident AF. A common characteristic of these diseases is that they increase atrial wall stretch. Multiple experimental studies confirm a proarrhythmic effect of atrial stretch. Conversely, a reduc-tion in stretch is antiarrhythmic. A therapeutic target for AF, there-fore, lies in local reduction of atrial stretch. This review focuses on atrial stretch and its clinical associations in patients with AF and its downstream effects on electrophysiology. We discuss the possible application of targeted atrial stretch reduction in AF prevention. We conclude that a reduction in local atrial stretch should be considered an essential element in rhythm control.